(Q33585362)

28 July 2017

1 reference

title

Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment (English)

1 reference

28 July 2017

1 reference

Snoeck R

1

1 reference

28 July 2017

Andrei G

series ordinal

2

1 reference

28 July 2017

De Clercq E

series ordinal

3

1 reference

28 July 2017

1 February 1999

1 reference

28 July 2017

1 reference

28 July 2017

57

1 reference

28 July 2017

2

1 reference

28 July 2017

187-206

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199957020-00005

28 July 2017

0 references

cites work

Foscarnet-resistant multidermatomal zoster in a patient with AIDS.

1 reference

12 December 2020

Varicella-Zoster infection in patients with cancer.

1 reference

12 December 2020

Random mutagenesis of the thymidine kinase gene of varicella-zoster virus

1 reference

12 December 2020

Bromovinyldeoxyurdine treatment of outer retinal necrosis due to varicella-zoster virus: a case-report.

1 reference

12 December 2020

Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus

1 reference

12 December 2020

The management of postherpetic neuralgia

1 reference

12 December 2020

Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis

1 reference

12 December 2020

Human Leukocyte Interferon for the Treatment of Varicella in Children with Cancer

1 reference

12 December 2020

Acyclovir in herpes zoster

1 reference

12 December 2020

Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox

1 reference

12 December 2020

Acyclovir treatment of varicella in otherwise healthy children

1 reference

12 December 2020

Pharmacokinetics of acyclovir after intravenous and oral administration.

1 reference

12 December 2020

Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).

1 reference

12 December 2020

Prevention of varicella by zoster immune globulin

1 reference

12 December 2020

TREATMENT OF HERPES ZOSTER WITH HIGH DOSES OF PREDNISONE

1 reference

12 December 2020

Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS.

1 reference

12 December 2020

Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines

1 reference

12 December 2020

Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group

1 reference

12 December 2020

Treatment of adult varicella with sorivudine: a randomized, placebo-controlled trial

1 reference

12 December 2020

Penetration of foscarnet into cerebrospinal fluid of AIDS patients

1 reference

12 December 2020

Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis

1 reference

12 December 2020

Human immunodeficiency virus infection and the skin

1 reference

12 December 2020

Varicella in children with cancer: impact of antiviral therapy and prophylaxis.

1 reference

12 December 2020

Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine treatment of severe herpes zoster in cancer patients

1 reference

12 December 2020

Therapeutic approaches to varicella-zoster virus infections

1 reference

12 December 2020

Molecular analysis of the thymidine kinase gene of thymidine kinase-deficient mutants of varicella-zoster virus

1 reference

12 December 2020

Comparative inhibition of DNA polymerases from varicella zoster virus (TK+ and TK-) strains by (E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-triphosphate

1 reference

12 December 2020

American Academy of Pediatrics Committee on Infectious Diseases: The use of oral acyclovir in otherwise healthy children with varicella

1 reference

12 December 2020

Oral acyclovir to prevent dissemination of varicella in immunocompromised children

1 reference

12 December 2020

Serologic response and reactogenicity to booster immunization of healthy seropositive adults with live or inactivated varicella vaccine

1 reference

12 December 2020

Herpes zoster: pathogenesis and latency

1 reference

12 December 2020

Varicella-zoster virus

1 reference

12 December 2020

Clinical uses of cidofovir

1 reference

12 December 2020

Antiviral therapy of acute herpes zoster in older patients

1 reference

12 December 2020

Oral acyclovir in the treatment of acute herpes zoster ophthalmicus

1 reference

12 December 2020

Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster

1 reference

12 December 2020

Immunization of the elderly and patients with collagen vascular diseases with live varicella vaccine and use of varicella skin antigen

1 reference

12 December 2020

Human immune responses to live attenuated varicella vaccine

1 reference

12 December 2020

Varicella in Pregnancy, the Fetus, and the Newborn: Problems in Management

1 reference

12 December 2020

Intracellular phosphorylation of broad-spectrum anti-DNA virus agent (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and inhibition of viral DNA synthesis

1 reference

12 December 2020

Flow cytometric method for the detection of gpI antigens of varicella zoster virus and evaluation of anti-VZV agents

1 reference

12 December 2020

Distribution of varicella zoster virus and herpes simplex virus in disseminated fatal infections.

1 reference

12 December 2020

6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus

1 reference

12 December 2020

Rhabdomyolysis associated with acute varicella infection

1 reference

12 December 2020

Human Leukocyte Interferon for the Treatment of Herpes Zoster in Patients with Cancer

1 reference

12 December 2020

Antiviral potencies of BV-araU and related nucleoside analogues against varicella-zoster virus in different cell lines

1 reference

12 December 2020

Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response

1 reference

12 December 2020

Treatment of adult chickenpox with oral acyclovir

1 reference

12 December 2020

Myelitis due to varicella-zoster virus in two patients with AIDS: successful treatment with acyclovir

1 reference

12 December 2020

A novel selective broad-spectrum anti-DNA virus agent

1 reference

12 December 2020

Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings

1 reference

12 December 2020

Frequent recurrence and persistence of varicella-zoster virus infections in children infected with human immunodeficiency virus type 1.

1 reference

12 December 2020

Oral acyclovir in the treatment of herpes zoster in general practice

1 reference

12 December 2020

Drug testing for activity against varicella-zoster virus in hairless guinea pigs

1 reference

12 December 2020

Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases

1 reference

12 December 2020

Acyclovir: A Decade Later

1 reference

12 December 2020

Chronic varicella zoster in a child infected with human immunodeficiency virus: case report and review of the literature

1 reference

12 December 2020

Severe but reversible neurotoxicity from acyclovir

1 reference

12 December 2020

Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies

1 reference

12 December 2020

Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, [...]

1 reference

12 December 2020

Enhancement of Varicella-Zoster-Specific Immune Responses in the Elderly by Boosting with Varicella Vaccine

1 reference

12 December 2020

A comparison of topical acyclovir with steroids in the treatment of herpes zoster keratouveitis

1 reference

12 December 2020

Disseminated herpes zoster in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers

1 reference

12 December 2020

Role of opportunistic viral infections in AIDS.

1 reference

12 December 2020

Oral BVDU treatment of varicella and zoster in children with cancer

1 reference

12 December 2020

New antiherpesvirus agents. Their targets and therapeutic potential

1 reference

12 December 2020

Varicella during pregnancy. Maternal and fetal effects

1 reference

12 December 2020

A double-blind clinical study in patients with herpes zoster to establish YN-72 (Brovavir) dose

1 reference

12 December 2020

Human Leukocyte Interferon in the Treatment of Varicella in Children with Cancer: a Preliminary Controlled Trial

1 reference

12 December 2020

Oral acyclovir prophylaxis of varicella after intimate contact

1 reference

12 December 2020

Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy.

1 reference

12 December 2020

Acyclovir triphosphate is a suicide inactivator of the herpes simplex virus DNA polymerase

1 reference

12 December 2020

Recognition and treatment of shingles

1 reference

12 December 2020

Zoster myelitis: improvement with antiviral therapy in two cases

1 reference

12 December 2020

Clinical pharmacology: foscarnet

1 reference

12 December 2020

Brain stem encephalitis due to varicella-zoster virus in a patient with AIDS.

1 reference

12 December 2020

Efficacy of oral acyclovir treatment of acute herpes zoster.

1 reference

12 December 2020

Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro

1 reference

12 December 2020

Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animals

1 reference

12 December 2020

In vitro susceptibility of varicella-zoster virus to acyclovir

1 reference

12 December 2020

Acyclovir-resistant varicella zoster responsive to foscarnet.

1 reference

12 December 2020

Varicella Vaccine: The American Experience

1 reference

12 December 2020

Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine

1 reference

12 December 2020

Varicella vaccine: its past, present and future

1 reference

12 December 2020

Virus infections in bone marrow transplant recipients: a three year prospective study

1 reference

12 December 2020

Herpes zoster-associated encephalitis: clinicopathologic report of 12 cases and review of the literature

1 reference

12 December 2020

Intravenous acyclovir in acute herpes zoster infection

1 reference

12 December 2020

Other neurological complications of herpes zoster and their management

1 reference

12 December 2020

Varicella zoster virus transverse myelitis without cutaneous rash

1 reference

12 December 2020

Pharmacokinetics of netivudine, a potent anti-varicella zoster virus drug, in patients with renal impairment

1 reference

12 December 2020

A randomised controlled study of intravenous acyclovir (Zovirax®) against placebo in adults with chickenpox

1 reference

12 December 2020

Successful treatment of varicella zoster virus meningoencephalitis in patients with AIDS: report of four cases and review.

1 reference

12 December 2020

Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial

1 reference

12 December 2020

Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus

1 reference

12 December 2020

In vitro activity of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against newly isolated clinical varicella-zoster virus strains

1 reference

12 December 2020

Famciclovir for the treatment of acute retinal necrosis (ARN) syndrome

1 reference

12 December 2020

A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster

1 reference

12 December 2020

Sorivudine: a potent inhibitor of varicella zoster virus replication.

1 reference

12 December 2020

Acute retinal necrosis in the course of AIDS: study of 26 cases

1 reference

12 December 2020

Oral acyclovir therapy for varicella and zoster infections in pediatric and pregnant patients: a brief review

1 reference

12 December 2020

Cytosine arabinoside therapy for herpesvirus infections

1 reference

12 December 2020

Advances and controversies in the antiviral therapy of herpes zoster

1 reference

12 December 2020

Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients

1 reference

12 December 2020

Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy

1 reference

12 December 2020

Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS).

1 reference

12 December 2020

Efficacy of A-73209, a potent orally active agent against VZV and HSV infections

1 reference

12 December 2020

Varicella-Zoster virus does not become more resistant to acyclovir during therapy

1 reference

12 December 2020

Evaluation of Varicella-Zoster Immune Globulin: Protection of Immunosuppressed Children after Household Exposure to Varicella

1 reference

12 December 2020

Effects of acyclovir on sensory axonal neuropathy, segmental motor paresis and postherpetic neuralgia in herpes zoster patients

1 reference

12 December 2020

2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir

1 reference

12 December 2020

The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis

1 reference

12 December 2020

Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus

1 reference

12 December 2020

Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

1 reference

12 December 2020

Progressive encephalitis three months after resolution of cutaneous zoster in a patient with AIDS.

1 reference

12 December 2020

Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults: retrospective controlled study and review

1 reference

12 December 2020

Varicella-zoster immune globulin for the prevention of chickenpox. Recommendations of the Immunization Practices Advisory Committee, Centers for Disease Control

1 reference

12 December 2020

The pharmacological profile of famciclovir.

1 reference

12 December 2020

Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group

1 reference

12 December 2020

Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections

1 reference

12 December 2020

Meningoradiculoneuritis due to acyclovir-resistant varicella zoster virus in an acquired immune deficiency syndrome patient

1 reference

12 December 2020

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine

1 reference

12 December 2020

Early herpes zoster infection in adult patients with Hodgkin's disease undergoing autologous bone marrow transplant

1 reference

12 December 2020

Clinical effect of BV-araU on varicella-zoster virus infection in immunocompromised patients with haematological malignancies

1 reference

12 December 2020

Parenteral and oral acyclovir for management of varicella pneumonia in pregnancy: a case report with review of literature

1 reference

12 December 2020

Neurologic Symptoms Associated with Parenteral Acyclovir Treatment After Marrow Transplantation

1 reference

12 December 2020

Preliminary results of oral BVDU treatment of herpes zoster ophthalmicus

1 reference

12 December 2020

Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group

1 reference

12 December 2020

Varicella in a susceptible pregnant woman.

1 reference

12 December 2020

Therapy of viral infections of the central nervous system

1 reference

12 December 2020

Immune response of elderly individuals to a live attenuated varicella vaccine

1 reference

12 December 2020

Risk factors for postherpetic neuralgia

1 reference

12 December 2020

Herpes zoster at the NIH: A 20 year experience

1 reference

12 December 2020

Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group

1 reference

12 December 2020

Zoster immune globulin. A further assessment.

1 reference

12 December 2020

VARICELLA PNEUMONIA: STUDY OF PREVALENCE IN ADULT MEN.

1 reference

12 December 2020

Inhibition of purified human and herpes simplex virus-induced DNA polymerases by 9-(2-hydroxyethoxymethyl)guanine triphosphate. Effects on primer-template function

1 reference

12 December 2020

Successors to acyclovir

1 reference

12 December 2020

Acyclovir Halts Progression of Herpes Zoster in Immunocompromised Patients

1 reference

12 December 2020

Varicella pneumonia in adults. Report of seven cases and a review of literature

1 reference

12 December 2020

Intrauterine Infection with Varicella-Zoster Virus after Maternal Varicella

1 reference

12 December 2020

Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study

1 reference

12 December 2020

2'-Fluoro-5-iodoarabinosylcytosine, a new potent antiviral agent: efficacy in immunosuppressed individuals with herpes zoster

1 reference

12 December 2020

Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention

1 reference

12 December 2020

Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]

1 reference

12 December 2020

Long-term protective immunity of recipients of the OKA strain of live varicella vaccine

1 reference

12 December 2020

The bioavailability and disposition of 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)uracil (882C87), a potent, new anti-varicella zoster virus agent

1 reference

12 December 2020

Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine

1 reference

12 December 2020

Varicella-zoster virus-specific immunity after herpes zoster

1 reference

12 December 2020

6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virus

1 reference

12 December 2020

Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture

1 reference

12 December 2020

Effect of (E)-5-(2-bromovinyl)uracil on the catabolism and antitumor activity of 5-fluorouracil in rats and leukemic mice.

1 reference

12 December 2020

Mutant varicella-zoster virus thymidine kinase: correlation of clinical resistance and enzyme impairment

1 reference

12 December 2020

Herpes and human ribonucleotide reductases. Inhibition by 2-acetylpyridine 5-[(2-chloroanilino)-thiocarbonyl]-thiocarbonohydrazone (348U87).

1 reference

12 December 2020

Oral brivudin vs. intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a randomized double-blind trial

1 reference

12 December 2020

Live vaccine used to prevent the spread of varicella in children in hospital

1 reference

12 December 2020

Use of acyclovir for varicella pneumonia during pregnancy.

1 reference

12 December 2020

Safety of famciclovir in patients with herpes zoster and genital herpes

1 reference

12 December 2020

Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine

1 reference

12 December 2020

Antiviral activity of oxetanocins against varicella-zoster virus

1 reference

12 December 2020

Acyclovir therapy of chickenpox in immunosuppressed children--a collaborative study

1 reference

12 December 2020

Acyclovir therapy for acute herpes zoster

1 reference

12 December 2020

Activity of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil against simian varicella virus infections in African green monkeys

1 reference

12 December 2020

Analysis of mutations in the thymidine kinase genes of drug-resistant varicella-zoster virus populations using the polymerase chain reaction

1 reference

12 December 2020

Acyclovir-induced renal failure: course and risk factors

1 reference

12 December 2020

Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine

1 reference

12 December 2020

Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis

1 reference

12 December 2020

Herpes simplex virus type 1 DNA polymerase. Mechanism of inhibition by acyclovir triphosphate

1 reference

12 December 2020

Varicella-Zoster Virus Reactivation without Rash

1 reference

12 December 2020

Strains of varicella-zoster virus resistant to 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil

1 reference

12 December 2020

Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus

1 reference

12 December 2020

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice.

1 reference

12 December 2020

Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS.

1 reference

12 December 2020

A controlled trial of acyclovir for chickenpox in normal children

1 reference

12 December 2020

Herpesvirus Infections in the Acquired Immune Deficiency Syndrome

1 reference

12 December 2020

Recommendations for the use of live attenuated varicella vaccine. American Academy of Pediatrics Committee on Infectious Diseases

1 reference

12 December 2020

Acute renal failure and coma secondary to acyclovir therapy

1 reference

12 December 2020

Herpes zoster ophthalmicus and the immunocompromised host: a case report and review.

1 reference

12 December 2020

Varicella-zoster virus: prospects for control.

1 reference

12 December 2020

Acyclovir prevents dissemination of varicella in immunocompromised children.

1 reference

12 December 2020

Vidarabine therapy of varicella in immunosuppressed patients

1 reference

12 December 2020

9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): a novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-Moloney murine sarcoma virus activity in vivo

1 reference

12 December 2020

Economic evaluation of famciclovir in reducing the duration of postherpetic neuralgia

1 reference

12 December 2020

Treatment of Varicella-Zoster Virus Infections with Adenine Arabinoside

1 reference

12 December 2020

The risk of zoster after varicella vaccination in children with leukemia

1 reference

12 December 2020

Varicella-zoster virus (VZV)-specific cytotoxicity after immunization of nonimmune adults with Oka strain attenuated VZV vaccine

1 reference

12 December 2020

Evaluation of infrequent dosing regimens with (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine (S-HPMPC) on simian varicella infection in monkeys

1 reference

12 December 2020

Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults

1 reference

12 December 2020

Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent

1 reference

12 December 2020

Persistence of protective immunity after postexposure prophylaxis of varicella with oral aciclovir in the family setting

1 reference

12 December 2020

The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group

1 reference

12 December 2020

Treatment of adult varicella with oral acyclovir. A randomized, placebo-controlled trial

1 reference

12 December 2020

Phenotypic and genotypic characterization of acyclovir-resistant varicella-zoster viruses isolated from persons with AIDS.

1 reference

12 December 2020

Herpes Zoster-Varicella infections and lymphoma

1 reference

12 December 2020

Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections

1 reference

12 December 2020

1 reference

12 December 2020

Fatal varicella-zoster virus meningoradiculitis without skin involvement

1 reference

12 December 2020

Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs

1 reference

12 December 2020

Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients

1 reference

12 December 2020

Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine

1 reference

12 December 2020

Prednisolone does not prevent post-herpetic neuralgia

1 reference

12 December 2020

The Effects of Early Corticosteroid Therapy on the Skin Eruption and Pain of Herpes Zoster

1 reference

12 December 2020

Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells

1 reference

12 December 2020

Fetal and neonatal varicella-zoster infections

1 reference

12 December 2020

(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication

1 reference

12 December 2020

Varicella pneumonia in adults: a spectrum of disease

1 reference

12 December 2020

NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention

1 reference

12 December 2020

Foscarnet Therapy in Five Patients with AIDS and Acyclovir-resistant Varicella-Zoster Virus Infection

1 reference

12 December 2020

Therapy of herpes zoster with oral acyclovir

1 reference

12 December 2020

Varicella-zoster virus myelitis: an expanding spectrum

1 reference

12 December 2020

10.2165/00003495-199957020-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference